Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1997 Nov;110(2):151-4.
doi: 10.1111/j.1365-2249.1997.tb08310.x.

Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation

S M McHugh  1 , T L Rowland
Affiliations
Review

Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation

S M McHugh et al. Clin Exp Immunol. 1997 Nov.
No abstract available

PubMed Disclaimer

References

    1. Hennies H-H, Günzler WA, Flohé L. Influence of supidimide on brain neurotransmitter systems of rats and mice. Arzneimittelforschugh. 1984;34:1471–80. - PubMed
    1. Sheskin J. Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther. 1965;6:303. - PubMed
    1. Sampaio EP, Kaplan G, Miranda A, et al. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis. 1993;168:408–14. - PubMed
    1. Gardner-Medwin J, Smith N, Powell R. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis. 1994;53:828–32. - PMC - PubMed
    1. Klausner JD, Freedman VH, Kaplan G. Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use. Clin Immunol Immunopathol. 996(81):219–23. - PubMed

MeSH terms